{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:16:10Z","timestamp":1790741770114,"version":"4.1.0"},"reference-count":139,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,16]],"date-time":"2015-03-16T00:00:00Z","timestamp":1426464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,3,16]],"date-time":"2015-03-16T00:00:00Z","timestamp":1426464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2016,1,7]]},"DOI":"10.1038\/onc.2015.63","type":"journal-article","created":{"date-parts":[[2015,3,16]],"date-time":"2015-03-16T11:10:32Z","timestamp":1426504232000},"page":"69-82","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["PML isoforms IV and V contribute to adenovirus-mediated oncogenic transformation by functionally inhibiting the tumor-suppressor p53"],"prefix":"10.1038","volume":"35","author":[{"given":"P","family":"Wimmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Berscheminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Blanchette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Groitl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P E","family":"Branton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R T","family":"Hay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Dobner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Schreiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,16]]},"reference":[{"key":"BFonc201563_CR1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1083\/jcb.131.1.45","volume":"131","author":"T Carvalho","year":"1995","unstructured":"Carvalho T, Seeler JS, \u00d6hman K, Jordan P, Pettersson U, Akusj\u00e4rvi G et al. Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies. J Cell Biol 1995; 131: 45\u201356.","journal-title":"J Cell Biol"},{"key":"BFonc201563_CR2","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/(SICI)1521-1878(199808)20:8<660::AID-BIES9>3.0.CO;2-M","volume":"20","author":"GG Maul","year":"1998","unstructured":"Maul GG . Nuclear domain 10, the site of DNA virus transcription and replication. Bioessays 1998; 20: 660\u2013667.","journal-title":"Bioessays"},{"key":"BFonc201563_CR3","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1083\/jcb.134.4.815","volume":"134","author":"AM Ishov","year":"1996","unstructured":"Ishov AM, Maul GG . The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition. J Cell Biol 1996; 134: 815\u2013826.","journal-title":"J Cell Biol"},{"key":"BFonc201563_CR4","doi-asserted-by":"crossref","first-page":"7325","DOI":"10.1128\/JVI.00723-08","volume":"82","author":"AJ Ullman","year":"2008","unstructured":"Ullman AJ, Hearing P . Cellular proteins PML and Daxx mediate an innate antiviral defense antagonized by the adenovirus E4 ORF3 protein. J Virol 2008; 82: 7325\u20137335.","journal-title":"J Virol"},{"key":"BFonc201563_CR5","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1128\/JVI.02385-06","volume":"81","author":"AJ Ullman","year":"2007","unstructured":"Ullman AJ, Reich NC, Hearing P . Adenovirus E4 ORF3 protein inhibits the interferon-mediated antiviral response. J Virol 2007; 81: 4744\u20134752.","journal-title":"J Virol"},{"key":"BFonc201563_CR6","doi-asserted-by":"crossref","first-page":"7029","DOI":"10.1128\/JVI.00074-10","volume":"84","author":"S Schreiner","year":"2010","unstructured":"Schreiner S, Wimmer P, Sirma H, Everett RD, Blanchette P, Groitl P et al. Proteasome-dependent degradation of Daxx by the viral E1B-55K protein in human adenovirus-infected cells. J Virol 2010; 84: 7029\u20137038.","journal-title":"J Virol"},{"key":"BFonc201563_CR7","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1038\/sj.onc.1211039","volume":"27","author":"B Hartl","year":"2008","unstructured":"Hartl B, Zeller T, Blanchette P, Kremmer E, Dobner T . Adenovirus type 5 early region 1B 55-kDa oncoprotein can promote cell transformation by a mechanism independent from blocking p53-activated transcription. Oncogene 2008; 27: 3673\u20133684.","journal-title":"Oncogene"},{"key":"BFonc201563_CR8","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1038\/onc.2010.284","volume":"29","author":"P Wimmer","year":"2010","unstructured":"Wimmer P, Schreiner S, Everett RD, Sirma H, Groitl P, Dobner T . SUMO modification of E1B-55K oncoprotein regulates isoform-specific binding to the tumour suppressor protein PML. Oncogene 2010; 29: 5511\u20135522.","journal-title":"Oncogene"},{"key":"BFonc201563_CR9","doi-asserted-by":"crossref","first-page":"12210","DOI":"10.1128\/JVI.01442-10","volume":"84","author":"MA Pennella","year":"2010","unstructured":"Pennella MA, Liu Y, Woo JL, Kim CA, Berk AJ . Adenovirus E1B 55-kilodalton protein is a p53-SUMO1 E3 ligase that represses p53 and stimulates its nuclear export through interactions with promyelocytic leukemia nuclear bodies. J Virol 2010; 84: 12210\u201312225.","journal-title":"J Virol"},{"key":"BFonc201563_CR10","doi-asserted-by":"crossref","first-page":"8752","DOI":"10.1128\/JVI.00440-11","volume":"85","author":"S Schreiner","year":"2011","unstructured":"Schreiner S, Wimmer P, Groitl P, Chen SY, Blanchette P, Branton PE et al. Adenovirus type 5 early region 1B 55K oncoprotein-dependent degradation of cellular factor Daxx is required for efficient transformation of primary rodent cells. J Virol 2011; 85: 8752\u20138765.","journal-title":"J Virol"},{"key":"BFonc201563_CR11","doi-asserted-by":"crossref","first-page":"7266","DOI":"10.1038\/sj.onc.1204759","volume":"20","author":"RD Everett","year":"2001","unstructured":"Everett RD . DNA viruses and viral proteins that interact with PML nuclear bodies. Oncogene 2001; 20: 7266\u20137273.","journal-title":"Oncogene"},{"key":"BFonc201563_CR12","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.biochi.2007.01.004","volume":"89","author":"RD Everett","year":"2007","unstructured":"Everett RD, Chelbi-Alix MK . PML and PML nuclear bodies: implications in antiviral defence. Biochimie 2007; 89: 819\u2013830.","journal-title":"Biochimie"},{"key":"BFonc201563_CR13","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/j.bbamcr.2008.08.004","volume":"1783","author":"N Tavalai","year":"2008","unstructured":"Tavalai N, Stamminger T . New insights into the role of the subnuclear structure ND10 for viral infection. Biochim Biophys Acta 2008; 1783: 2207\u20132221.","journal-title":"Biochim Biophys Acta"},{"key":"BFonc201563_CR14","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.2741\/3889","volume":"17","author":"E Van Damme","year":"2011","unstructured":"Van Damme E, Van Ostade X . Crosstalk between viruses and PML nuclear bodies: a network-based approach. Front Biosci 2011; 17: 2910\u20132920.","journal-title":"Front Biosci"},{"key":"BFonc201563_CR15","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1083\/jcb.112.5.785","volume":"112","author":"CA Ascoli","year":"1991","unstructured":"Ascoli CA, Maul GG . Identification of a novel nuclear domain. J Cell Biol 1991; 112: 785\u2013795.","journal-title":"J Cell Biol"},{"key":"BFonc201563_CR16","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0092-8674(94)90340-9","volume":"76","author":"JA Dyck","year":"1994","unstructured":"Dyck JA, Maul GG, Miller WH Jr, Chen JD, Kakizuka A, Evans RM . A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 1994; 76: 333\u2013343.","journal-title":"Cell"},{"key":"BFonc201563_CR17","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/j.1460-2075.1994.tb06356.x","volume":"13","author":"MH Koken","year":"1994","unstructured":"Koken MH, Puvion-Dutilleul F, Guillemin MC, Viron A, Linares-Cruz G, Stuurman N et al. The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J 1994; 13: 1073\u20131083.","journal-title":"EMBO J"},{"key":"BFonc201563_CR18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0092-8674(94)90341-7","volume":"76","author":"K Weis","year":"1994","unstructured":"Weis K, Rambaud S, Lavau C, Jansen J, Carvalho T, Carmo-Fonseca M et al. Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell 1994; 76: 345\u2013356.","journal-title":"Cell"},{"key":"BFonc201563_CR19","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0092-8674(91)90113-D","volume":"66","author":"H de The","year":"1991","unstructured":"de The H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A . The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 1991; 66: 675\u2013684.","journal-title":"Cell"},{"key":"BFonc201563_CR20","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0092-8674(91)90112-C","volume":"66","author":"A Kakizuka","year":"1991","unstructured":"Kakizuka A, Miller WH Jr, Umesono K, Warrell RP Jr, Frankel SR, Murty VV et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 1991; 66: 663\u2013674.","journal-title":"Cell"},{"key":"BFonc201563_CR21","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/j.1460-2075.1992.tb05185.x","volume":"11","author":"PP Pandolfi","year":"1992","unstructured":"Pandolfi PP, Alcalay M, Fagioli M, Zangrilli D, Mencarelli A, Diverio D et al. Genomic variability and alternative splicing generate multiple PML\/RAR alpha transcripts that encode aberrant PML proteins and PML\/RAR alpha isoforms in acute promyelocytic leukaemia. EMBO J 1992; 11: 1397\u20131407.","journal-title":"EMBO J"},{"key":"BFonc201563_CR22","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/j.1460-2075.1992.tb05095.x","volume":"11","author":"P Kastner","year":"1992","unstructured":"Kastner P, Perez A, Lutz Y, Rochette Egly C, Gaub MP, Durand B et al. Structure, localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins. EMBO J 1992; 11: 629\u2013642.","journal-title":"EMBO J"},{"issue":"Suppl 3","key":"BFonc201563_CR23","first-page":"117S","volume":"6","author":"AD Goddard","year":"1992","unstructured":"Goddard AD, Borrow J, Solomon E . A previously uncharacterized gene, PML, is fused to the retinoic acid receptor alpha gene in acute promyelocytic leukaemia. Leukemia 1992; 6 (Suppl 3): 117S\u2013119SS.","journal-title":"Leukemia"},{"key":"BFonc201563_CR24","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/sj.leu.2401513","volume":"13","author":"A Melnick","year":"1999","unstructured":"Melnick A, Fruchtman S, Zelent A, Liu M, Huang Q, Boczkowska B et al. Identification of novel chromosomal rearrangements in acute myelogenous leukemia involving loci on chromosome 2p23, 15q22 and 17q21. Leukemia 1999; 13: 1534\u20131538.","journal-title":"Leukemia"},{"key":"BFonc201563_CR25","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1182\/blood.V93.10.3167.410k44_3167_3215","volume":"93","author":"A Melnick","year":"1999","unstructured":"Melnick A, Licht JD . Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 1999; 93: 3167\u20133215.","journal-title":"Blood"},{"key":"BFonc201563_CR26","first-page":"800","volume":"12","author":"KS Chang","year":"1992","unstructured":"Chang KS, Stass SA, Chu DT, Deaven LL, Trujillo JM, Freireich EJ . Characterization of a fusion cDNA (RARA\/myl) transcribed from the t(15;17) translocation breakpoint in acute promyelocytic leukemia. Mol Cell Biol 1992; 12: 800\u2013810.","journal-title":"Mol Cell Biol"},{"key":"BFonc201563_CR27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/jnci\/djh043","volume":"96","author":"C Gurrieri","year":"2004","unstructured":"Gurrieri C, Capodieci P, Bernardi R, Scaglioni PP, Nafa K, Rush LJ et al. Loss of the tumor suppressor PML in human cancers of multiple histologic origins. J Natl Cancer Inst 2004; 96: 269\u2013279.","journal-title":"J Natl Cancer Inst"},{"key":"BFonc201563_CR28","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1084\/jem.193.12.1361","volume":"193","author":"V Lallemand-Breitenbach","year":"2001","unstructured":"Lallemand-Breitenbach V, Zhu J, Puvion F, Koken M, Honore N, Doubeikovsky A et al. Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11 S proteasome recruitment, and As2O3-induced PML or PML\/retinoic acid receptor alpha degradation. J Exp Med 2001; 193: 1361\u20131371.","journal-title":"J Exp Med"},{"key":"BFonc201563_CR29","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1128\/MCB.20.5.1784-1796.2000","volume":"20","author":"H Li","year":"2000","unstructured":"Li H, Leo C, Zhu J, Wu X, O'Neil J, Park EJ et al. Sequestration and inhibition of Daxx-mediated transcriptional repression by PML. Mol Cell Biol 2000; 20: 1784\u20131796.","journal-title":"Mol Cell Biol"},{"key":"BFonc201563_CR30","doi-asserted-by":"crossref","first-page":"E85","DOI":"10.1038\/35010583","volume":"2","author":"S Zhong","year":"2000","unstructured":"Zhong S, Salomoni P, Pandolfi PP . The transcriptional role of PML and the nuclear body. Nat Cell Biol 2000; 2: E85\u2013E90.","journal-title":"Nat Cell Biol"},{"key":"BFonc201563_CR31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/35018127","volume":"406","author":"M Pearson","year":"2000","unstructured":"Pearson M, Carbone R, Sebastiani C, Cioce M, Fagioli M, Saito S et al. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 2000; 406: 207\u2013210.","journal-title":"Nature"},{"key":"BFonc201563_CR32","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1101\/gad.14.16.2015","volume":"14","author":"G Ferbeyre","year":"2000","unstructured":"Ferbeyre G, de Stanchina E, Querido E, Baptiste N, Prives C, Lowe SW . PML is induced by oncogenic ras and promotes premature senescence. Genes Dev 2000; 14: 2015\u20132027.","journal-title":"Genes Dev"},{"key":"BFonc201563_CR33","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1093\/emboj\/cdf341","volume":"21","author":"O Bischof","year":"2002","unstructured":"Bischof O, Kirsh O, Pearson M, Itahana K, Pelicci PG, Dejean A . Deconstructing PML-induced premature senescence. Embo J 2002; 21: 3358\u20133369.","journal-title":"Embo J"},{"key":"BFonc201563_CR34","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1093\/emboj\/21.10.2383","volume":"21","author":"E Langley","year":"2002","unstructured":"Langley E, Pearson M, Faretta M, Bauer UM, Frye RA, Minucci S et al. Human SIR2 deacetylates p53 and antagonizes PML\/p53-induced cellular senescence. Embo J 2002; 21: 2383\u20132396.","journal-title":"Embo J"},{"key":"BFonc201563_CR35","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/cr.2008.58","volume":"18","author":"P Salomoni","year":"2008","unstructured":"Salomoni P, Ferguson BJ, Wyllie AH, Rich T . New insights into the role of PML in tumour suppression. Cell Res 2008; 18: 622\u2013640.","journal-title":"Cell Res"},{"key":"BFonc201563_CR36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(02)00626-8","volume":"108","author":"P Salomoni","year":"2002","unstructured":"Salomoni P, Pandolfi PP . The role of PML in tumor suppression. Cell 2002; 108: 165\u2013170.","journal-title":"Cell"},{"key":"BFonc201563_CR37","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1083\/jcb.153.2.367","volume":"153","author":"O Bischof","year":"2001","unstructured":"Bischof O, Kim SH, Irving J, Beresten S, Ellis NA, Campisi J . Regulation and localization of the Bloom syndrome protein in response to DNA damage. J Cell Biol 2001; 153: 367\u2013380.","journal-title":"J Cell Biol"},{"key":"BFonc201563_CR38","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/sj.onc.1205227","volume":"21","author":"R Carbone","year":"2002","unstructured":"Carbone R, Pearson M, Minucci S, Pelicci PG . PML NBs associate with the hMre11 complex and p53 at sites of irradiation induced DNA damage. Oncogene 2002; 21: 1633\u20131640.","journal-title":"Oncogene"},{"key":"BFonc201563_CR39","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1038\/sj.onc.1207533","volume":"23","author":"Y Takahashi","year":"2004","unstructured":"Takahashi Y, Lallemand-Breitenbach V, Zhu J, de The H . PML nuclear bodies and apoptosis. Oncogene 2004; 23: 2819\u20132824.","journal-title":"Oncogene"},{"key":"BFonc201563_CR40","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/sj.cdd.4401313","volume":"10","author":"TG Hofmann","year":"2003","unstructured":"Hofmann TG, Will H . Body language: the function of PML nuclear bodies in apoptosis regulation. Cell Death Differ 2003; 10: 1290\u20131299.","journal-title":"Cell Death Differ"},{"key":"BFonc201563_CR41","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2741\/3311","volume":"14","author":"D Torok","year":"2009","unstructured":"Torok D, Ching RW, Bazett-Jones DP . PML nuclear bodies as sites of epigenetic regulation. Front Biosci 2009; 14: 1325\u20131336.","journal-title":"Front Biosci"},{"key":"BFonc201563_CR42","doi-asserted-by":"crossref","first-page":"7223","DOI":"10.1038\/sj.onc.1204765","volume":"20","author":"K Jensen","year":"2001","unstructured":"Jensen K, Shiels C, Freemont PS . PML protein isoforms and the RBCC\/TRIM motif. Oncogene 2001; 20: 7223\u20137233.","journal-title":"Oncogene"},{"key":"BFonc201563_CR43","first-page":"1083","volume":"7","author":"M Fagioli","year":"1992","unstructured":"Fagioli M, Alcalay M, Pandolfi PP, Venturini L, Mencarelli A, Simeone A et al. Alternative splicing of PML transcripts predicts coexpression of several carboxy-terminally different protein isoforms. Oncogene 1992; 7: 1083\u20131091.","journal-title":"Oncogene"},{"key":"BFonc201563_CR44","first-page":"2565","volume":"11","author":"M Stadler","year":"1995","unstructured":"Stadler M, Chelbi-Alix MK, Koken MH, Venturini L, Lee C, Saib A et al. Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. Oncogene 1995; 11: 2565\u20132573.","journal-title":"Oncogene"},{"key":"BFonc201563_CR45","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S1097-2765(04)00062-0","volume":"13","author":"E de Stanchina","year":"2004","unstructured":"de Stanchina E, Querido E, Narita M, Davuluri RV, Pandolfi PP, Ferbeyre G et al. PML is a direct p53 target that modulates p53 effector functions. Mol Cell 2004; 13: 523\u2013535.","journal-title":"Mol Cell"},{"key":"BFonc201563_CR46","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1073\/pnas.012317299","volume":"99","author":"A Kentsis","year":"2002","unstructured":"Kentsis A, Gordon RE, Borden KL . Self-assembly properties of a model RING domain. Proc Natl Acad Sci USA 2002; 99: 667\u2013672.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc201563_CR47","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fonc.2013.00125","volume":"3","author":"S Nisole","year":"2013","unstructured":"Nisole S, Maroui MA, Mascle XH, Aubry M, Chelbi-Alix MK . Differential Roles of PML Isoforms. Front Oncol 2013; 3: 125.","journal-title":"Front Oncol"},{"key":"BFonc201563_CR48","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/emboj\/17.1.61","volume":"17","author":"S Muller","year":"1998","unstructured":"Muller S, Matunis MJ, Dejean A . Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. Embo J 1998; 17: 61\u201370.","journal-title":"Embo J"},{"issue":"Pt 24","key":"BFonc201563_CR49","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1242\/jcs.112.24.4581","volume":"112","author":"RD Everett","year":"1999","unstructured":"Everett RD, Lomonte P, Sternsdorf T, van Driel R, Orr A . Cell cycle regulation of PML modification and ND10 composition. J Cell Sci 1999; 112 (Pt 24): 4581\u20134588.","journal-title":"J Cell Sci"},{"key":"BFonc201563_CR50","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1182\/blood.V95.9.2748.009k31a_2748_2752","volume":"95","author":"S Zhong","year":"2000","unstructured":"Zhong S, Muller S, Ronchetti S, Freemont PS, Dejean A, Pandolfi PP . Role of SUMO-1-modified PML in nuclear body formation. Blood 2000; 95: 2748\u20132752.","journal-title":"Blood"},{"key":"BFonc201563_CR51","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cell.2006.05.041","volume":"126","author":"PP Scaglioni","year":"2006","unstructured":"Scaglioni PP, Yung TM, Cai LF, Erdjument-Bromage H, Kaufman AJ, Singh B et al. A CK2-dependent mechanism for degradation of the PML tumor suppressor. Cell 2006; 126: 269\u2013283.","journal-title":"Cell"},{"key":"BFonc201563_CR52","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1158\/0008-5472.CAN-05-3792","volume":"66","author":"W Condemine","year":"2006","unstructured":"Condemine W, Takahashi Y, Zhu J, Puvion-Dutilleul F, Guegan S, Janin A et al. Characterization of endogenous human promyelocytic leukemia isoforms. Cancer Res 2006; 66: 6192\u20136198.","journal-title":"Cancer Res"},{"issue":"Pt 3","key":"BFonc201563_CR53","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1242\/jcs.112.3.381","volume":"112","author":"E Duprez","year":"1999","unstructured":"Duprez E, Saurin AJ, Desterro JM, Lallemand-Breitenbach V, Howe K, Boddy MN et al. SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation. J Cell Sci 1999; 112 (Pt 3): 381\u2013393.","journal-title":"J Cell Sci"},{"key":"BFonc201563_CR54","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.bbrc.2005.09.090","volume":"337","author":"D Owerbach","year":"2005","unstructured":"Owerbach D, McKay EM, Yeh ET, Gabbay KH, Bohren KM . A proline-90 residue unique to SUMO-4 prevents maturation and sumoylation. Biochem Biophys Res Commun 2005; 337: 517\u2013520.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFonc201563_CR55","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1128\/JVI.06227-11","volume":"86","author":"P Wimmer","year":"2012","unstructured":"Wimmer P, Schreiner S, Dobner T . Human pathogens and the host cell SUMOylation system. J Virol 2012; 86: 642\u2013654.","journal-title":"J Virol"},{"key":"BFonc201563_CR56","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1073\/pnas.81.18.5734","volume":"81","author":"KP Haley","year":"1984","unstructured":"Haley KP, Overhauser J, Babiss LE, Ginsberg HS, Jones NC . Transformation properties of type 5 adenovirus mutants that differentially express the E1 A gene products. Proc Natl Acad Sci USA 1984; 81: 5734\u20135738.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc201563_CR57","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1128\/jvi.57.3.765-775.1986","volume":"57","author":"E Moran","year":"1986","unstructured":"Moran E, Grodzicker T, Roberts RJ, Mathews MB, Zerler B . Lytic and transforming functions of individual products of the adenovirus E1A gene. J Virol 1986; 57: 765\u2013775.","journal-title":"J Virol"},{"key":"BFonc201563_CR58","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1101\/gad.7.4.535","volume":"7","author":"SW Lowe","year":"1993","unstructured":"Lowe SW, Ruley HE . Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev 1993; 7: 535\u2013545.","journal-title":"Genes Dev"},{"key":"BFonc201563_CR59","doi-asserted-by":"crossref","first-page":"7836","DOI":"10.1038\/sj.onc.1204861","volume":"20","author":"E White","year":"2001","unstructured":"White E . Regulation of the cell cycle and apoptosis by the oncogenes of adenovirus. Oncogene 2001; 20: 7836\u20137846.","journal-title":"Oncogene"},{"key":"BFonc201563_CR60","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1099\/0022-1317-72-6-1467","volume":"72","author":"W McLorie","year":"1991","unstructured":"McLorie W, McGlade CJ, Takayesu D, Branton PE . Individual adenovirus E1B proteins induce transformation independently but by additive pathways. J Gen Virol 1991; 72: 1467\u20131471.","journal-title":"J Gen Virol"},{"key":"BFonc201563_CR61","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/304602a0","volume":"304","author":"HE Ruley","year":"1983","unstructured":"Ruley HE . Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature 1983; 304: 602\u2013606.","journal-title":"Nature"},{"key":"BFonc201563_CR62","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1073\/pnas.91.6.2026","volume":"91","author":"SW Lowe","year":"1994","unstructured":"Lowe SW, Jacks T, Housman DE, Ruley HE . Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. Proc Natl Acad Sci USA 1994; 91: 2026\u20132030.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc201563_CR63","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3181\/00379727-204-43631","volume":"204","author":"E White","year":"1993","unstructured":"White E . Regulation of apoptosis by the transforming genes of the DNA tumor virus adenovirus. Proc Soc Exp Biol Med 1993; 204: 30\u201339.","journal-title":"Proc Soc Exp Biol Med"},{"key":"BFonc201563_CR64","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/0042-6822(90)90148-K","volume":"179","author":"CC Kao","year":"1990","unstructured":"Kao CC, Yew PR, Berk AJ . Domains required for in vitro association between the cellular p53 and the adenovirus 2 E1B 55K proteins. Virology 1990; 179: 806\u2013814.","journal-title":"Virology"},{"key":"BFonc201563_CR65","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0092-8674(82)90356-7","volume":"28","author":"P Sarnow","year":"1982","unstructured":"Sarnow P, Ho YS, Williams J, Levine AJ . Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell 1982; 28: 387\u2013394.","journal-title":"Cell"},{"key":"BFonc201563_CR66","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1101\/gad.8.2.190","volume":"8","author":"PR Yew","year":"1994","unstructured":"Yew PR, Liu X, Berk AJ . Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53. Genes Dev 1994; 8: 190\u2013202.","journal-title":"Genes Dev"},{"key":"BFonc201563_CR67","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1128\/MCB.19.5.3403","volume":"19","author":"ME Martin","year":"1999","unstructured":"Martin ME, Berk AJ . Corepressor required for adenovirus E1B 55,000-molecular-weight protein repression of basal transcription. Mol Cell Biol 1999; 19: 3403\u20133414.","journal-title":"Mol Cell Biol"},{"key":"BFonc201563_CR68","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0042-6822(85)90421-0","volume":"142","author":"A Zantema","year":"1985","unstructured":"Zantema A, Fransen JA, Davis OA, Ramaekers FC, Vooijs GP, DeLeys B et al. Localization of the E1B proteins of adenovirus 5 in transformed cells, as revealed by interaction with monoclonal antibodies. Virology 1985; 142: 44\u201358.","journal-title":"Virology"},{"key":"BFonc201563_CR69","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1128\/JVI.01608-06","volume":"81","author":"T Sieber","year":"2007","unstructured":"Sieber T, Dobner T . Adenovirus type 5 early region 1B 156 R protein promotes cell transformation independently of repression of p53-stimulated transcription. J Virol 2007; 81: 95\u2013105.","journal-title":"J Virol"},{"key":"BFonc201563_CR70","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/sj.onc.1208170","volume":"24","author":"C Endter","year":"2005","unstructured":"Endter C, Hartl B, Spruss T, Hauber J, Dobner T . Blockage of CRM1-dependent nuclear export of the adenovirus type 5 early region 1B 55-kDa protein augments oncogenic transformation of primary rat cells. Oncogene 2005; 24: 55\u201364.","journal-title":"Oncogene"},{"key":"BFonc201563_CR71","doi-asserted-by":"crossref","first-page":"11312","DOI":"10.1073\/pnas.191361798","volume":"98","author":"C Endter","year":"2001","unstructured":"Endter C, Kzhyshkowska J, Stauber R, Dobner T . SUMO-1 modification required for transformation by adenovirus type 5 early region 1B 55-kDa oncoprotein. Proc Natl Acad Sci USA 2001; 98: 11312\u201311317.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc201563_CR72","first-page":"3084","volume":"5","author":"A Zantema","year":"1985","unstructured":"Zantema A, Schrier PI, Davis OA, van Laar T, Vaessen RT, van der Eb AJ . Adenovirus serotype determines association and localization of the large E1B tumor antigen with cellular tumor antigen p53 in transformed cells. Mol Cell Biol 1985; 5: 3084\u20133091.","journal-title":"Mol Cell Biol"},{"key":"BFonc201563_CR73","doi-asserted-by":"crossref","first-page":"6323","DOI":"10.1128\/jvi.70.9.6323-6335.1996","volume":"70","author":"FD Goodrum","year":"1996","unstructured":"Goodrum FD, Shenk T, Ornelles DA . Adenovirus early region 4 34-kilodalton protein directs the nuclear localization of the early region 1B 55-kilodalton protein in primate cells. J Virol 1996; 70: 6323\u20136335.","journal-title":"J Virol"},{"key":"BFonc201563_CR74","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1128\/JVI.73.3.2253-2262.1999","volume":"73","author":"C K\u00f6nig","year":"1999","unstructured":"K\u00f6nig C, Roth J, Dobbelstein M . Adenovirus type 5 E4orf3 protein relieves p53 inhibition by E1B-55-kilodalton protein. J Virol 1999; 73: 2253\u20132262.","journal-title":"J Virol"},{"key":"BFonc201563_CR75","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/sj.onc.1203395","volume":"19","author":"F Kr\u00e4tzer","year":"2000","unstructured":"Kr\u00e4tzer F, Rosorius O, Heger P, Hirschmann N, Dobner T, Hauber J et al. The adenovirus type 5 E1B-55k oncoprotein is a highly active shuttle protein and shuttling is independent of E4orf6, p53 and Mdm2. Oncogene 2000; 19: 850\u2013857.","journal-title":"Oncogene"},{"key":"BFonc201563_CR76","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1128\/JVI.74.1.193-202.2000","volume":"74","author":"S Wienzek","year":"2000","unstructured":"Wienzek S, Roth J, Dobbelstein M . E1B 55-kilodalton oncoproteins of adenovirus types 5 and 12 inactivate and relocalize p53, but not p51 or p73, and cooperate with E4orf6 proteins to destabilize p53. J Virol 2000; 74: 193\u2013202.","journal-title":"J Virol"},{"key":"BFonc201563_CR77","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.1128\/JVI.75.12.5677-5683.2001","volume":"75","author":"T Dosch","year":"2001","unstructured":"Dosch T, Horn F, Schneider G, Kr\u00e4tzer F, Dobner T, Hauber J et al. The adenovirus type 5 E1B-55K oncoprotein actively shuttles in virus-infected cells, whereas transport of E4orf6 is mediated by a CRM1 independent-mechanism. J Virol 2001; 75: 5677\u20135683.","journal-title":"J Virol"},{"key":"BFonc201563_CR78","doi-asserted-by":"crossref","first-page":"754","DOI":"10.4161\/cc.7.6.5495","volume":"7","author":"S Muller","year":"2008","unstructured":"Muller S, Dobner T . The adenovirus E1B-55K oncoprotein induces SUMO modification of p53. Cell Cycle 2008; 7: 754\u2013758.","journal-title":"Cell Cycle"},{"key":"BFonc201563_CR79","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1128\/JVI.72.4.3146-3154.1998","volume":"72","author":"ME Martin","year":"1998","unstructured":"Martin ME, Berk AJ . Adenovirus E1B 55K represses p53 activation in vitro. J Virol 1998; 72: 3146\u20133154.","journal-title":"J Virol"},{"key":"BFonc201563_CR80","doi-asserted-by":"crossref","first-page":"9045","DOI":"10.1128\/JVI.00728-09","volume":"83","author":"K Kindsmuller","year":"2009","unstructured":"Kindsmuller K, Schreiner S, Leinenkugel F, Groitl P, Kremmer E, Dobner T . A 49-kilodalton isoform of the adenovirus type 5 early region 1B 55-kilodalton protein is sufficient to support virus replication. J Virol 2009; 83: 9045\u20139056.","journal-title":"J Virol"},{"key":"BFonc201563_CR81","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1038\/onc.2012.187","volume":"32","author":"P Wimmer","year":"2013","unstructured":"Wimmer P, Blanchette P, Schreiner S, Ching W, Groitl P, Berscheminski J et al. Cross-talk between phosphorylation and SUMOylation regulates transforming activities of an adenoviral oncoprotein. Oncogene 2013; 32: 1626\u20131637.","journal-title":"Oncogene"},{"key":"BFonc201563_CR82","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1126\/science.279.5356.1547","volume":"279","author":"ZG Wang","year":"1998","unstructured":"Wang ZG, Delva L, Gaboli M, Rivi R, Giorgio M, Cordon-Cardo C et al. Role of PML in cell growth and the retinoic acid pathway. Science 1998; 279: 1547\u20131551.","journal-title":"Science"},{"key":"BFonc201563_CR83","first-page":"67","volume":"780","author":"PE Branton","year":"1985","unstructured":"Branton PE, Bayley ST, Graham FL . Transformation by human adenoviruses. Biochim Biophys Acta 1985; 780: 67\u201394.","journal-title":"Biochim Biophys Acta"},{"key":"BFonc201563_CR84","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/978-1-4684-7935-5_9","volume-title":"The Adenoviruses","author":"FL Graham","year":"1984","unstructured":"Graham FL . Transformation by and oncogenicity of human adenoviruses. In: Ginsberg HS (ed). The Adenoviruses. Plenum Press: New York, pp 339\u2013398 1984."},{"key":"BFonc201563_CR85","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/978-1-4899-1100-1_11","volume-title":"DNA Tumor Viruses: Oncogenic Mechanisms","author":"RP Ricciardi","year":"1995","unstructured":"Ricciardi RP . Transformation and tumorigenesis mediated by the adenovirus E1A and E1B oncogenes. In: Barbanti-Brodano G (ed). DNA Tumor Viruses: Oncogenic Mechanisms. Plenum Press: New York, pp 195\u2013210 1995."},{"key":"BFonc201563_CR86","first-page":"301","volume-title":"Virology Fields Virology 1","author":"JR Nevins","year":"1996","unstructured":"Nevins JR, Vogt PK . Cell transformation by viruses. In: Fields BN, Knipe DM, Howley PM (eds). Virology Fields Virology 1, Third edn. Lippincott-Raven: New York, pp, 301\u2013343 1996."},{"key":"BFonc201563_CR87","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.1038\/sj.onc.1204913","volume":"20","author":"PH Gallimore","year":"2001","unstructured":"Gallimore PH, Turnell AS . Adenovirus E1A: remodelling the host cell, a life or death experience. Oncogene 2001; 20: 7824\u20137835.","journal-title":"Oncogene"},{"key":"BFonc201563_CR88","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1126\/science.137.3533.835","volume":"137","author":"JJ Trentin","year":"1962","unstructured":"Trentin JJ, Yabe Y, Taylor G . The quest for human cancer viruses: a new approach to an old problem reveals cancer induction in hamster hy human adenoviruses. Science 1962; 137: 835\u2013849.","journal-title":"Science"},{"key":"BFonc201563_CR89","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1099\/0022-1317-36-1-59","volume":"36","author":"FL Graham","year":"1977","unstructured":"Graham FL, Smiley J, Russel WC, Nairn R . Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977; 36: 59\u201372.","journal-title":"J Gen Virol"},{"key":"BFonc201563_CR90","first-page":"110","volume":"4","author":"JL Whittaker","year":"1984","unstructured":"Whittaker JL, Byrd PJ, Grand RJ, Gallimore PH . Isolation and characterization of four adenovirus type 12-transformed human embryo kidney cell lines. Mol Cell Biol 1984; 4: 110\u2013116.","journal-title":"Mol Cell Biol"},{"key":"BFonc201563_CR91","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1128\/jvi.66.1.591-595.1992","volume":"66","author":"SJL van den Heuvel","year":"1992","unstructured":"van den Heuvel SJL, The SI, Klein B, Jochemsen AG, Zantema A, van der Eb AJ . p53 shares an antigenic determinant with proteins of 92 and 150 kilodaltons that may be involved in senescence of human cells. J Virol 1992; 66: 591\u2013595.","journal-title":"J Virol"},{"key":"BFonc201563_CR92","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1089\/hum.1998.9.13-1909","volume":"9","author":"FJ Fallaux","year":"1998","unstructured":"Fallaux FJ, Bout A, van der Velde I, van den Wollenberg DJ, Hehir KM, Keegan J et al. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum Gene Ther 1998; 9: 1909\u20131917.","journal-title":"Hum Gene Ther"},{"key":"BFonc201563_CR93","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/hum.1996.7.2-215","volume":"7","author":"FJ Fallaux","year":"1996","unstructured":"Fallaux FJ, Kranenburg O, Cramer SJ, Houweling A, Van Ormondt H, Hoeben RC et al. Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum Gene Ther 1996; 7: 215\u2013222.","journal-title":"Hum Gene Ther"},{"issue":"3 Pt B","key":"BFonc201563_CR94","first-page":"499","volume":"6","author":"PH Gallimore","year":"1986","unstructured":"Gallimore PH, Grand RJ, Byrd PJ . Transformation of human embryo retinoblasts with simian virus 40, adenovirus and ras oncogenes. Anticancer Res 1986; 6 (3 Pt B): 499\u2013508.","journal-title":"Anticancer Res"},{"key":"BFonc201563_CR95","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1089\/104303400750001417","volume":"11","author":"G Schiedner","year":"2000","unstructured":"Schiedner G, Hertel S, Kochanek S . Efficient transformation of primary human amniocytes by E1 functions of ad5: generation of new cell lines for adenoviral vector production. Hum Gene Ther 2000; 11: 2105\u20132116.","journal-title":"Hum Gene Ther"},{"key":"BFonc201563_CR96","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/298069a0","volume":"298","author":"P Byrd","year":"1982","unstructured":"Byrd P, Brown KW, Gallimore PH . Malignant transformation of human embryo retinoblasts by cloned adenovirus 12 DNA. Nature 1982; 298: 69\u201371.","journal-title":"Nature"},{"key":"BFonc201563_CR97","first-page":"163","volume":"273","author":"C Endter","year":"2004","unstructured":"Endter C, Dobner T . Cell transformation by human adenoviruses. Curr Top Microbiol Immunol 2004; 273: 163\u2013214.","journal-title":"Curr Top Microbiol Immunol"},{"key":"BFonc201563_CR98","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/jcp.1041210418","volume":"3","author":"FL Graham","year":"1984","unstructured":"Graham FL, Rowe DT, McKinnon R, Bacchetti S, Ruben M, Branton PE . Transformation by human adenoviruses. J Cell Physiol Suppl 1984; 3: 151\u2013163.","journal-title":"J Cell Physiol Suppl"},{"key":"BFonc201563_CR99","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/BF00354296","volume":"6","author":"AD Goddard","year":"1995","unstructured":"Goddard AD, Yuan JQ, Fairbairn L, Dexter M, Borrow J, Kozak C et al. Cloning of the murine homolog of the leukemia-associated PML gene. Mamm Genome 1995; 6: 732\u2013737.","journal-title":"Mamm Genome"},{"key":"BFonc201563_CR100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.7150\/ijbs.6.51","volume":"6","author":"E Van Damme","year":"2010","unstructured":"Van Damme E, Laukens K, Dang TH, Van Ostade X . A manually curated network of the PML nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics. Int J Biol Sci 2010; 6: 51\u201367.","journal-title":"Int J Biol Sci"},{"key":"BFonc201563_CR101","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1757-5036-3-3","volume":"3","author":"P Brand","year":"2010","unstructured":"Brand P, Lenser T, Hemmerich P . Assembly dynamics of PML nuclear bodies in living cells. PMC Biophys 2010; 3: 3.","journal-title":"PMC Biophys"},{"key":"BFonc201563_CR102","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1242\/jcs.031922","volume":"121","author":"S Weidtkamp-Peters","year":"2008","unstructured":"Weidtkamp-Peters S, Lenser T, Negorev D, Gerstner N, Hofmann TG, Schwanitz G et al. Dynamics of component exchange at PML nuclear bodies. J Cell Sci 2008; 121: 2731\u20132743.","journal-title":"J Cell Sci"},{"key":"BFonc201563_CR103","doi-asserted-by":"crossref","first-page":"30729","DOI":"10.1074\/jbc.M112.374769","volume":"287","author":"Y Geng","year":"2012","unstructured":"Geng Y, Monajembashi S, Shao A, Cui D, He W, Chen Z et al. Contribution of the C-terminal regions of promyelocytic leukemia protein (PML) isoforms II and V to PML nuclear body formation. J Biol Chem 2012; 287: 30729\u201330742.","journal-title":"J Biol Chem"},{"key":"BFonc201563_CR104","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1182\/blood-2003-07-2200","volume":"103","author":"C Gurrieri","year":"2004","unstructured":"Gurrieri C, Nafa K, Merghoub T, Bernardi R, Capodieci P, Biondi A et al. Mutations of the PML tumor suppressor gene in acute promyelocytic leukemia. Blood 2004; 103: 2358\u20132362.","journal-title":"Blood"},{"key":"BFonc201563_CR105","first-page":"1315","volume":"10","author":"MH Koken","year":"1995","unstructured":"Koken MH, Linares-Cruz G, Quignon F, Viron A, Chelbi-Alix MK, Sobczak-Th\u00e8pot J et al. The PML growth-suppressor has an altered expression in human oncognesis. Oncogene 1995; 10: 1315\u20131324.","journal-title":"Oncogene"},{"key":"BFonc201563_CR106","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1128\/JVI.02023-12","volume":"87","author":"J Berscheminski","year":"2013","unstructured":"Berscheminski J, Groitl P, Dobner T, Wimmer P, Schreiner S . The adenoviral oncogene E1A-13S interacts with a specific isoform of the tumor suppressor PML to enhance viral transcription. J Virol 2013; 87: 965\u2013977.","journal-title":"J Virol"},{"key":"BFonc201563_CR107","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1101\/gad.7.4.546","volume":"7","author":"M Debbas","year":"1993","unstructured":"Debbas M, White E . Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev 1993; 7: 546\u2013554.","journal-title":"Genes Dev"},{"key":"BFonc201563_CR108","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1006\/viro.1994.1480","volume":"203","author":"RJ Grand","year":"1994","unstructured":"Grand RJ, Grant ML, Gallimore PH . Enhanced expression of p53 in human cells infected with mutant adenoviruses. Virology 1994; 203: 229\u2013240.","journal-title":"Virology"},{"key":"BFonc201563_CR109","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1101\/gad.9.17.2184","volume":"9","author":"P Sabbatini","year":"1995","unstructured":"Sabbatini P, Lin J, Levine AJ, White E . Essential role for p53-mediated transcription in E1A-induced apoptosis. Genes Dev 1995; 9: 2184\u20132192.","journal-title":"Genes Dev"},{"key":"BFonc201563_CR110","doi-asserted-by":"crossref","first-page":"12094","DOI":"10.1073\/pnas.94.22.12094","volume":"94","author":"AV Samuelson","year":"1997","unstructured":"Samuelson AV, Lowe SW . Selective induction of p53 and chemosensitivity in RB-deficient cells by E1A mutants unable to bind the RB-related proteins. Proc Natl Acad Sci USA 1997; 94: 12094\u201312099.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc201563_CR111","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1093\/emboj\/19.17.4759","volume":"19","author":"AS Turnell","year":"2000","unstructured":"Turnell AS, Grand RJ, Gorbea C, Zhang X, Wang W, Mymryk JS et al. Regulation of the 26S proteasome by adenovirus E1A. Embo J 2000; 19: 4759\u20134773.","journal-title":"Embo J"},{"key":"BFonc201563_CR112","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1128\/jvi.71.5.3526-3533.1997","volume":"71","author":"E Querido","year":"1997","unstructured":"Querido E, Teodoro JG, Branton PE . Accumulation of p53 induced by the adenovirus E1A protein requires regions involved in the stimulation of DNA synthesis. J Virol 1997; 71: 3526\u20133533.","journal-title":"J Virol"},{"key":"BFonc201563_CR113","doi-asserted-by":"crossref","first-page":"6684","DOI":"10.1073\/pnas.0702158104","volume":"104","author":"K Kindsm\u00fcller","year":"2007","unstructured":"Kindsm\u00fcller K, Groitl P, H\u00e4rtl B, Blanchette P, Hauber J, Dobner T . Intranuclear targeting and nuclear export of the adenovirus E1B-55K protein are regulated by SUMO1 conjugation. Proc Natl Acad Sci USA 2007; 104: 6684\u20136689.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc201563_CR114","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1099\/vir.0.18820-0","volume":"84","author":"KJ Lethbridge","year":"2003","unstructured":"Lethbridge KJ, Scott GE, Leppard KN . Nuclear matrix localization and SUMO-1 modification of adenovirus type 5 E1b 55K protein are controlled by E4 Orf6 protein. J Gen Virol 2003; 84: 259\u2013268.","journal-title":"J Gen Virol"},{"key":"BFonc201563_CR115","doi-asserted-by":"crossref","first-page":"13321","DOI":"10.1074\/jbc.275.18.13321","volume":"275","author":"S M\u00fcller","year":"2000","unstructured":"M\u00fcller S, Berger M, Lehembre F, Seeler JS, Haupt Y, Dejean A . c-Jun and p53 activity is modulated by SUMO-1 modification. J Biol Chem 2000; 275: 13321\u201313329.","journal-title":"J Biol Chem"},{"key":"BFonc201563_CR116","doi-asserted-by":"crossref","first-page":"6462","DOI":"10.1093\/emboj\/18.22.6462","volume":"18","author":"M Gostissa","year":"1999","unstructured":"Gostissa M, Hengstermann A, Fogal V, Sandy P, Schwarz SE, Scheffner M et al. Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J 1999; 18: 6462\u20136471.","journal-title":"EMBO J"},{"key":"BFonc201563_CR117","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1097-2765(01)00349-5","volume":"8","author":"T Kahyo","year":"2001","unstructured":"Kahyo T, Nishida T, Yasuda H . Involvement of PIAS1 in the sumoylation of tumor suppressor p53. Mol Cell 2001; 8: 713\u2013718.","journal-title":"Mol Cell"},{"key":"BFonc201563_CR118","doi-asserted-by":"crossref","first-page":"6455","DOI":"10.1093\/emboj\/18.22.6455","volume":"18","author":"MS Rodriguez","year":"1999","unstructured":"Rodriguez MS, Desterro JM, Lain S, Midgley CA, Lane DP, Hay RT . SUMO-1 modification activates the transcriptional response of p53. EMBO J 1999; 18: 6455\u20136461.","journal-title":"EMBO J"},{"key":"BFonc201563_CR119","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1073\/pnas.052559499","volume":"99","author":"D Schmidt","year":"2002","unstructured":"Schmidt D, M\u00fcller S . Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity. Proc Natl Acad Sci USA 2002; 99: 2872\u20132877.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc201563_CR120","doi-asserted-by":"crossref","first-page":"9048","DOI":"10.1038\/sj.onc.1207106","volume":"22","author":"R Bernardi","year":"2003","unstructured":"Bernardi R, Pandolfi PP . Role of PML and the PML-nuclear body in the control of programmed cell death. Oncogene 2003; 22: 9048\u20139057.","journal-title":"Oncogene"},{"key":"BFonc201563_CR121","doi-asserted-by":"crossref","first-page":"6185","DOI":"10.1093\/emboj\/19.22.6185","volume":"19","author":"V Fogal","year":"2000","unstructured":"Fogal V, Gostissa M, Sandy P, Zacchi P, Sternsdorf T, Jensen K et al. Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J 2000; 19: 6185\u20136195.","journal-title":"EMBO J"},{"key":"BFonc201563_CR122","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/35036365","volume":"2","author":"A Guo","year":"2000","unstructured":"Guo A, Salomoni P, Luo J, Shih A, Zhong S, Gu W et al. The function of PML in p53-dependent apoptosis. Nat Cell Biol 2000; 2: 730\u2013736.","journal-title":"Nat Cell Biol"},{"key":"BFonc201563_CR123","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0955-0674(03)00038-3","volume":"15","author":"M Gostissa","year":"2003","unstructured":"Gostissa M, Hofmann TG, Will H, del Sal G . Regulation of p53 functions: let's meet at the nuclear bodies. Curr Opin Cell Biol 2003; 15: 351\u2013357.","journal-title":"Curr Opin Cell Biol"},{"key":"BFonc201563_CR124","doi-asserted-by":"crossref","first-page":"7250","DOI":"10.1038\/sj.onc.1204856","volume":"20","author":"MPP Pearson","year":"2001","unstructured":"Pearson MPP . PML interactions with p53 and its role in apoptosis and replicative senescence. Oncogene 2001; 20: 7250\u20137256.","journal-title":"Oncogene"},{"key":"BFonc201563_CR125","first-page":"25","volume":"259","author":"T Dobner","year":"2001","unstructured":"Dobner T, Kzhyshkowska J . Nuclear export of adenovirus RNA. Curr Top Microbiol Immunol 2001; 259: 25\u201354.","journal-title":"Curr Top Microbiol Immunol"},{"key":"BFonc201563_CR126","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1128\/JVI.75.2.699-709.2001","volume":"75","author":"E Querido","year":"2001","unstructured":"Querido E, Morisson MR, Chu-Pham-Dang H, Thirlwell SW, Boivin D, Branton PE . Identification of three functions of the adenovirus E4orf6 protein that mediate p53 degradation by the E4orf6-E1B55K complex. J Virol 2001; 75: 699\u2013709.","journal-title":"J Virol"},{"key":"BFonc201563_CR127","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nature00863","volume":"418","author":"TH Stracker","year":"2002","unstructured":"Stracker TH, Carson CT, Weitzman MD . Adenovirus oncoproteins inactivate the Mre11 Rad50 NBS1 DNA repair complex. Nature 2002; 418: 348\u2013352.","journal-title":"Nature"},{"key":"BFonc201563_CR128","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1128\/JVI.00029-07","volume":"81","author":"A Baker","year":"2007","unstructured":"Baker A, Rohleder KJ, Hanakahi LA, Ketner G . Adenovirus E4 34k and E1b 55k oncoproteins target host DNA ligase IV for proteasomal degradation. J Virol 2007; 81: 7034\u20137040.","journal-title":"J Virol"},{"key":"BFonc201563_CR129","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.1128\/JVI.00089-09","volume":"83","author":"F Dallaire","year":"2009","unstructured":"Dallaire F, Blanchette P, Groitl P, Dobner T, Branton PE . Identification of integrin alpha3 as a new substrate of the adenovirus E4orf6\/E1B 55-kilodalton E3 ubiquitin ligase complex. J Virol 2009; 83: 5329\u20135338.","journal-title":"J Virol"},{"key":"BFonc201563_CR130","doi-asserted-by":"crossref","first-page":"9619","DOI":"10.1128\/MCB.24.21.9619-9629.2004","volume":"24","author":"P Blanchette","year":"2004","unstructured":"Blanchette P, Cheng CY, Yan Q, Ketner G, Ornelles DA, Dobner T et al. Both BC-box motifs of adenovirus protein E4orf6 are required to efficiently assemble an E3 ligase complex that degrades p53. Mol Cell Biol 2004; 24: 9619\u20139629.","journal-title":"Mol Cell Biol"},{"key":"BFonc201563_CR131","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1101\/gad.926401","volume":"15","author":"E Querido","year":"2001","unstructured":"Querido E, Blanchette P, Yan Q, Kamura T, Morrison M, Boivin D et al. Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex. Genes Dev 2001; 15: 3104\u20133117.","journal-title":"Genes Dev"},{"key":"BFonc201563_CR132","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1128\/jvi.71.5.3788-3798.1997","volume":"71","author":"E Querido","year":"1997","unstructured":"Querido E, Marcellus RC, Lai A, Charbonneau R, Teodoro JG, Ketner G et al. Regulation of p53 levels by the E1B 55-kilodalton protein and E4orf6 in adenovirus-infected cells. J Virol 1997; 71: 3788\u20133798.","journal-title":"J Virol"},{"key":"BFonc201563_CR133","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1128\/jvi.49.3.692-700.1984","volume":"49","author":"P Sarnow","year":"1984","unstructured":"Sarnow P, Hearing P, Anderson CW, Halbert DN, Shenk T, Levine AJ . Adenovirus early region 1B 58,000-dalton tumor antigen is physically associated with an early region 4 25,000-dalton protein in productively infected cells. J Virol 1984; 49: 692\u2013700.","journal-title":"J Virol"},{"key":"BFonc201563_CR134","first-page":"171","volume":"7","author":"T Mitsudomi","year":"1992","unstructured":"Mitsudomi T, Steinberg SM, Nau MM, Carbone D, D'Amico D, Bodner HK et al. p53 gene mutations in non-small-lung cell cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene 1992; 7: 171\u2013180.","journal-title":"Oncogene"},{"key":"BFonc201563_CR135","first-page":"187","volume-title":"Adenovirus Methods and Protocols Methods in Molecular Medicine 2","author":"M Nevels","year":"2006","unstructured":"Nevels M, Dobner T . Determination of the transforming activities of adenovirus oncogenes. In: Wold WS, Tollefson AE (eds). Adenovirus Methods and Protocols Methods in Molecular Medicine 2 2nd edn. Humana Press Inc.: Totowa, NJ, pp 187\u2013195 2006."},{"key":"BFonc201563_CR136","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1126\/science.272.5267.1470","volume":"272","author":"T Dobner","year":"1996","unstructured":"Dobner T, Horikoshi N, Rubenwolf S, Shenk T . Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor. Science 1996; 272: 1470\u20131473.","journal-title":"Science"},{"key":"BFonc201563_CR137","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1002\/j.1460-2075.1994.tb06807.x","volume":"13","author":"K Okamoto","year":"1994","unstructured":"Okamoto K, Beach D . Cyclin G is a transcriptional target of the p53 tumor suppressor protein. Embo J 1994; 13: 4816\u20134822.","journal-title":"Embo J"},{"key":"BFonc201563_CR138","first-page":"527","volume":"2","author":"J Logan","year":"1984","unstructured":"Logan J, Pilder S, Shenk T . Functional analysis of adenovirus type 5 early region 1B. Cancer Cells 1984; 2: 527\u2013532.","journal-title":"Cancer Cells"},{"key":"BFonc201563_CR139","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/0042-6822(82)90054-X","volume":"120","author":"P Sarnow","year":"1982","unstructured":"Sarnow P, Sullivan CA, Levine AJ . A monoclonal antibody detecting the adenovirus type 5-E1b-58Kd tumor antigen: characterization of the E1b-58Kd tumor antigen in adenovirus-infected and -transformed cells. Virology 1982; 120: 510\u2013517.","journal-title":"Virology"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc201563.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc201563","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc201563.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T20:55:11Z","timestamp":1647896111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc201563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,16]]},"references-count":139,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1,7]]}},"alternative-id":["BFonc201563"],"URL":"https:\/\/doi.org\/10.1038\/onc.2015.63","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,16]]},"assertion":[{"value":"30 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"PW is currently an employee of Novartis. The remaining authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}